医学
不利影响
抗抑郁药
神经保护
临床试验
传统医学
重症监护医学
萧条(经济学)
精神科
药理学
焦虑
内科学
宏观经济学
经济
作者
Sze Yuen Lew,Seong Lin Teoh,Siew‐Huah Lim,Lee Wei Lim,Kah-Hui Wong
出处
期刊:Mini-reviews in Medicinal Chemistry
[Bentham Science]
日期:2020-10-16
卷期号:20 (15): 1518-1531
被引量:9
标识
DOI:10.2174/1389557520666200526125534
摘要
Depression is the most common form of mental illness and the major cause of disability worldwide. Symptoms of depression, including feelings of intense sadness and hopelessness, may occur after a specific event or in response to a gradual decline in health and functional status, often associated with aging. Current therapies for treating these symptoms include antidepressant drugs, counseling and behavioral therapy. However, antidepressant drugs are associated with mild to severe adverse effects, which has prompted the need for better treatment options. Medicinal mushrooms are valuable sources of food and medicine and are increasingly being used as supplements or as alternative medicines in standard healthcare. Numerous studies have provided insights into the neuroprotective effects of medicinal mushrooms, which are attributed to their antioxidant, anti-neuroinflammatory, cholinesterase inhibitory and neuroprotective properties. In this review, we comprehensively examine the role of these medicinal mushrooms in the treatment of depression. However, to apply these natural products in clinical settings, the therapeutic agent needs to be properly evaluated, including the active ingredients, the presence of synergistic effects, efficient extraction methods, and stabilization of the active ingredients for delivery into the body as well as crossing the blood-brain barrier.
科研通智能强力驱动
Strongly Powered by AbleSci AI